AAAAAA

   
Results: 1-16 |
Results: 16
OUTCOME OF PERIPHERAL-BLOOD STEM-CELL MOBILIZATION IN ADVANCED PHASESOF CML IS DEPENDENT ON THE TYPE OF CHEMOTHERAPY APPLIED
Authors: FISCHER T NEUBAUER A MOHM J HUHN D BUSEMANN C LINK H ARSENIEV L BUSSING B NOVOTNY J GANSER A DUYSTER J BUNJES D WESTERMEIER T FLOHR T DESPRES D GAMM H DECKER J DERIGS G AULITZKY W HUBER C
Citation: T. Fischer et al., OUTCOME OF PERIPHERAL-BLOOD STEM-CELL MOBILIZATION IN ADVANCED PHASESOF CML IS DEPENDENT ON THE TYPE OF CHEMOTHERAPY APPLIED, Annals of hematology, 77(1-2), 1998, pp. 21-26
CHEMOTHERAPY-INDUCED MOBILIZATION OF KARYOTYPICALLY NORMAL PBSC FOR AUTOGRAFTING IN CML
Authors: FISCHER T NEUBAUER A MOHM J HUHN D BUSEMANN C LINK H ARSENIEV L BUSSING B NOVOTNY J GANSER A DUYSTER J BUNJES D KREITER S AULITZKY W HEHLMANN R HUBER C
Citation: T. Fischer et al., CHEMOTHERAPY-INDUCED MOBILIZATION OF KARYOTYPICALLY NORMAL PBSC FOR AUTOGRAFTING IN CML, Bone marrow transplantation, 21(10), 1998, pp. 1029-1036
TISSUE POLYPEPTIDE-SPECIFIC - ANTIGEN IN RENAL-CELL CARCINOMA
Authors: HOBARTH K HALLAS A KRAMER G AULITZKY W GOMAHR A STEINER G MARBERGER M
Citation: K. Hobarth et al., TISSUE POLYPEPTIDE-SPECIFIC - ANTIGEN IN RENAL-CELL CARCINOMA, European urology, 30(1), 1996, pp. 89-95
CIRCULATING IMMUNE MARKERS IN ADVANCED RENAL-CELL CARCINOMA DURING IMMUNOTHERAPY WITH INTERFERON-GAMMA
Authors: HOBARTH K HALLAS A STEINER G GOMAHR A AULITZKY W MARBERGER M
Citation: K. Hobarth et al., CIRCULATING IMMUNE MARKERS IN ADVANCED RENAL-CELL CARCINOMA DURING IMMUNOTHERAPY WITH INTERFERON-GAMMA, Urological research, 24(2), 1996, pp. 101-106
CD4 MONOCLONAL-ANTIBODY VIT4 IN HUMAN ALLOIMMUNE RESPONSE IN-VITRO AND IN-VIVO
Authors: NACHBAUR D NIEDERWIESER D AICHINGER G AULITZKY W TILG H EIBL B KONIG P GATTRINGER C MAJDIC O STOCKINGER H MARGREITER R OBERHUBER G FODINGER AM SCHWAIGHOFER H HUBER C
Citation: D. Nachbaur et al., CD4 MONOCLONAL-ANTIBODY VIT4 IN HUMAN ALLOIMMUNE RESPONSE IN-VITRO AND IN-VIVO, Immunobiology, 195(1), 1996, pp. 33-46
MAJOR HISTOCOMPATIBILITY COMPLEX CLASS-I AND CLASS-II EXPRESSION IN RENAL-CELL CARCINOMA AND MODULATION BY INTERFERON-GAMMA
Authors: GASTL G EBERT T FINSTAD CL SHEINFELD J GOMAHR A AULITZKY W BANDER NH
Citation: G. Gastl et al., MAJOR HISTOCOMPATIBILITY COMPLEX CLASS-I AND CLASS-II EXPRESSION IN RENAL-CELL CARCINOMA AND MODULATION BY INTERFERON-GAMMA, The Journal of urology, 155(1), 1996, pp. 361-367
CYTOKINES
Authors: KATH R AULITZKY W HOFFKEN K
Citation: R. Kath et al., CYTOKINES, Der Internist, 37(10), 1996, pp. 1075-1081
CYTOKINES
Authors: KATH R AULITZKY W HOFFKEN K
Citation: R. Kath et al., CYTOKINES, Der Gynakologe, 29(5), 1996, pp. 395-401
MILD CHEMOTHERAPY CAN MOBILIZE PHILADELPHIA-NEGATIVE CD34-POSITIVE CELLS IN LATE CHRONIC PHASE OF CHRONIC MYELOGENOUS LEUKEMIA (CML)
Authors: BUSEMANN C AULITZKY W NAGEL S BAURMANN H KREISSIG C SALAMA A SIEGERT W HUHN D HUBER C NEUBAUER A
Citation: C. Busemann et al., MILD CHEMOTHERAPY CAN MOBILIZE PHILADELPHIA-NEGATIVE CD34-POSITIVE CELLS IN LATE CHRONIC PHASE OF CHRONIC MYELOGENOUS LEUKEMIA (CML), Blood, 88(10), 1996, pp. 3511-3511
EXPRESSION OF C-FOS CORRELATES WITH IFN-ALPHA RESPONSIVENESS IN PHILADELPHIA-CHROMOSOME-POSITIVE CHRONIC MYELOGENOUS LEUKEMIA
Authors: EIBL B GREITER E GRUNEWALD K GASTL G WEYRER K THALER J AULITZKY W HERRMANN F RAPP U HUBER C
Citation: B. Eibl et al., EXPRESSION OF C-FOS CORRELATES WITH IFN-ALPHA RESPONSIVENESS IN PHILADELPHIA-CHROMOSOME-POSITIVE CHRONIC MYELOGENOUS LEUKEMIA, Cytokines and molecular therapy, 1(1), 1995, pp. 29-38
INTERMITTENT LOW-DOSE IFN-GAMMA TREATMENT FOR METASTATIC RENAL-CELL CARCINOMA - ANALYSIS OF FACTORS PREDICTING CLINICAL-RESPONSE AND LONG-TERM SURVIVAL
Authors: AULITZKY WE AULITZKY W ELLERHORST J LOGOTHETIS C GOMAHR A STOCKLE M THEWS O SCHEIBENBOGEN C KEILHOLZ U HUBER C
Citation: We. Aulitzky et al., INTERMITTENT LOW-DOSE IFN-GAMMA TREATMENT FOR METASTATIC RENAL-CELL CARCINOMA - ANALYSIS OF FACTORS PREDICTING CLINICAL-RESPONSE AND LONG-TERM SURVIVAL, Onkologie, 18(4), 1995, pp. 339-345
HEPATOCYTE GROWTH FACTOR-SCATTER FACTOR EXPRESSION IN MYELOIC AND B-LYMPHOCYTIC CELLS SUGGESTS PARACRINE STIMULATION OF LIVER-REGENERATION BY INFLAMMATORY CELLS
Authors: SCHIRMACHER P BEILMANN M ODENTHAL M AULITZKY W DIENES HP
Citation: P. Schirmacher et al., HEPATOCYTE GROWTH FACTOR-SCATTER FACTOR EXPRESSION IN MYELOIC AND B-LYMPHOCYTIC CELLS SUGGESTS PARACRINE STIMULATION OF LIVER-REGENERATION BY INFLAMMATORY CELLS, Hepatology, 22(4), 1995, pp. 1027-1027
LOW-DOSE GAMMA-INTERFERON THERAPY IS INEFFECTIVE IN RENAL-CELL CARCINOMA PATIENTS WITH LARGE TUMOR BURDEN
Authors: AULITZKY WE LERCHE J THEWS A LUTTICHAU I JACOBI N HEROLD M AULITZKY W PESCHEL C STOCKLE M STEINBACH F HUBER C
Citation: We. Aulitzky et al., LOW-DOSE GAMMA-INTERFERON THERAPY IS INEFFECTIVE IN RENAL-CELL CARCINOMA PATIENTS WITH LARGE TUMOR BURDEN, European journal of cancer, 30A(7), 1994, pp. 940-945
SERUM NEOPTERIN AS A PARAMETER FOR MONITORING THE COURSE OF PENAL CELL-CARCINOMA DURING INTERFERON-GAMMA THERAPY
Authors: HOBARTH K SZABO N HALLAS A AULITZKY W MARBERGER M
Citation: K. Hobarth et al., SERUM NEOPTERIN AS A PARAMETER FOR MONITORING THE COURSE OF PENAL CELL-CARCINOMA DURING INTERFERON-GAMMA THERAPY, Clinical immunology and immunopathology, 70(3), 1994, pp. 241-244
RENAL ECHINOCOCCUS ALVEOLARIS (MULTILOCUL ARIS) - A DIAGNOSTIC CHALLENGE - COMMENTARY
Authors: AULITZKY W
Citation: W. Aulitzky, RENAL ECHINOCOCCUS ALVEOLARIS (MULTILOCUL ARIS) - A DIAGNOSTIC CHALLENGE - COMMENTARY, Aktuelle Urologie, 25(5), 1994, pp. 317-317
INHALATIVE APPLICATION OF NATURAL INTERLEUKIN-2 (NIL-2) IN MALIGNANT LUNG-DISEASE
Authors: LORENZ J WILHELM K MULLERQUERNHEIM J AULITZKY W
Citation: J. Lorenz et al., INHALATIVE APPLICATION OF NATURAL INTERLEUKIN-2 (NIL-2) IN MALIGNANT LUNG-DISEASE, The American review of respiratory disease, 147(4), 1993, pp. 748-748
Risultati: 1-16 |